CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Genentech in up to $2.3B deal with Hanmi for novel weight loss drug

Positive
AI Analysis

Summary

Genentech has entered into a deal with Hanmi valued at up to $2.3B to acquire rights to a novel weight loss drug.

Importance:7/10
Sentiment:
0.60
acquisitionweight lossM&Anovel drug
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 25, 2026 1:26 PM

Read Original